Try Claude
Academic ResearchSearch papers, authors, citations
AI Tools for Bioinformatics Scientists
AI tools that help bioinformatics scientists search genomic literature, identify research tools, visualize biological data, and stay current with computational biology advances.
Get started for free
Works in Chat, Cowork and Code
ESMFold (Meta AI)
Single-sequence folding via language model · 2022 · 1,840 citations
RoseTTAFold2
Multi-track attention, improved accuracy on novel folds · 2023 · 890 citations
ProteinMPNN
Inverse folding for de novo protein design · 2022 · 1,200 citations
Trend
Focus shifting to multi-chain complexes and drug-binding pockets in 2024–2025
Genomics and computational biology literature review
Search the latest peer-reviewed papers across genomics, transcriptomics, proteomics, and computational biology. Find benchmark studies comparing tools, identify state-of-the-art methods, and surface citation networks for any analytical approach.
Find papers benchmarking single-cell RNA-seq trajectory inference methods. I need comparison papers covering Monocle3, Slingshot, PAGA, and Velocity published from 2020 onwards.
Found 22 benchmark papers. Key reference: Saelens et al. (Nature Biotechnology, 2021) — gold-standard benchmark across 45 methods. Slingshot ranks highest for linear trajectories; PAGA excels for complex topologies. Velocity methods top performers for dynamical systems but require spliced/unspliced count matrices.
ToolRouter search_papers
Top Reference
Saelens et al. Nat Biotech 2021 · 45 methods compared · 2,100 citations
Best: Linear Trajectories
Slingshot — highest accuracy, flexible graph topology
Best: Complex Topologies
PAGA — graph abstraction, scales to millions of cells
Best: Dynamical
scVelo (Velocity) — requires spliced/unspliced count matrices
Biological compound and protein data lookup
Look up chemical properties, molecular formulas, and structural data for compounds, amino acids, and proteins. Support molecular biology work with compound identity verification and property data.
Look up the molecular properties of doxorubicin including its molecular formula, weight, mechanism of action, and known DNA interaction sites.
Doxorubicin: molecular formula C27H29NO11, MW 543.52 g/mol. Mechanism: intercalates DNA at GC-rich sequences and inhibits topoisomerase II, preventing replication. Also generates reactive oxygen species via semiquinone radical cycling. Key binding domain: anthracycline chromophore intercalation between base pairs.
ToolRouter search_compound
Formula / MW
C27H29NO11 · 543.52 g/mol · CAS 23214-92-8
Mechanism
DNA intercalation at GC sequences + Topoisomerase II inhibition
ROS Generation
Semiquinone radical cycling → superoxide → oxidative DNA damage
DNA Binding
Anthracycline chromophore intercalates between base pairs · daunosamine sugar anchors in minor groove
Biological data visualization
Create charts for gene expression analysis, survival curves, enrichment scores, and variant allele frequency distributions. Produce figures suitable for manuscripts and lab presentations.
Create a volcano plot showing log2 fold change (x-axis, range -5 to +5) vs. -log10 adjusted p-value (y-axis, range 0 to 15) for RNA-seq differential expression. Mark the significance thresholds at |FC|>2 and padj<0.05.
Generated a volcano plot with significance thresholds marked as dashed lines: vertical at ±1 log2FC and horizontal at -log10(0.05)=1.30. Quadrants labeled: up-regulated (top right), down-regulated (top left), not significant (bottom). Exportable as high-resolution PNG for manuscript submission.
ToolRouter create_chart
Significant Up
Significant Down
Not Significant
Bioinformatics pipeline documentation
Create workflow diagrams documenting analysis pipelines for methods sections, lab SOPs, and tool documentation. Visualize complex multi-step computational workflows clearly.
Generate a workflow diagram for a whole exome sequencing (WES) analysis pipeline: FASTQ → FastQC → Trimmomatic → BWA-MEM → GATK HaplotypeCaller → VQSR → Variant Annotation (VEP) → Filtering → VCF output.
Generated a 9-step linear pipeline diagram with tool names and output file types at each step. Decision diamond after VQSR for variant quality threshold. Tool version annotations added at FastQC, BWA-MEM, and GATK steps. Suitable for methods section or onboarding documentation.
Clinical trial biomarker landscape research
Identify clinical trials using genomic or proteomic biomarkers as endpoints or eligibility criteria. Understand how biomarkers you work with are being used in clinical development.
Find oncology trials that use tumor mutational burden (TMB) or microsatellite instability (MSI) status as biomarker eligibility criteria or endpoints. Focus on recruiting trials in the US.
Found 47 trials using TMB or MSI criteria. 28 use MSI-H as an eligibility biomarker, 15 use TMB ≥10 mut/Mb as a stratification factor, and 4 are biomarker-agnostic with TMB/MSI as an exploratory endpoint. Pan-tumor basket designs dominate recent trials.
ToolRouter search_trials
Nct IDIndicationBiomarker
NCT05812345Pan-tumor basketMSI-H
NCT06124780Colorectal cancerMSI-H / dMMR
NCT05934201NSCLCTMB ≥ 10 mut/Mb
NCT06078932Gastric cancerTMB (exploratory)
47 total trials · 28 MSI-H · 15 TMB ≥10 · 4 exploratory
Drug target and pathway research
Research the biological mechanisms underlying drug targets, pathway interactions, and drug resistance mechanisms. Support target selection and mechanistic hypothesis generation.
Research the PI3K/AKT/mTOR pathway and currently approved drugs targeting it. Include mechanism, approved indications, and known resistance mutations.
Found 6 FDA-approved PI3K/AKT/mTOR inhibitors. Alpelisib (PI3Kα, PIK3CA-mutant breast cancer), idelalisib (PI3Kδ, CLL/FL), everolimus/temsirolimus (mTORC1, RCC/PNET). Key resistance mechanisms: PTEN loss, AKT amplification, and KRAS co-mutations conferring bypass signaling.
ToolRouter search_papers
Alpelisib (PI3Kα)
PIK3CA-mutant HR+/HER2- breast cancer · FDA 2019 · companion dx required
Idelalisib (PI3Kδ)
CLL + follicular lymphoma · FDA 2014 · immune-mediated toxicity risk
Everolimus (mTORC1)
RCC, PNET, HR+ breast cancer · FDA 2009–2012 · oral daily dosing
Resistance: PTEN Loss
Activates AKT independent of PI3K inhibition — bypass mechanism
Resistance: KRAS Co-mutation
RAS/MAPK bypass signaling — reduces PI3Ki single-agent efficacy
Ready-to-use prompts
Benchmark tool comparison
Find benchmark papers comparing RNA-seq alignment tools: STAR, HISAT2, and Salmon. What are the recommended tools for speed vs. accuracy trade-offs in 2023-2024 publications?
Compound properties
Look up the molecular structure, formula, and biochemical properties of cisplatin. Include its mechanism of DNA crosslinking and key resistance mechanisms.
Gene expression chart
Create a bar chart with error bars showing mean expression levels (FPKM) for 8 genes across 3 conditions: control, treatment A, and treatment B. Use a grouped bar layout.
Pipeline workflow diagram
Create a workflow diagram for a ChIP-seq analysis pipeline: FASTQ input → quality control → adapter trimming → alignment → peak calling (MACS2) → IDR filtering → motif analysis → annotation.
Biomarker trial search
Find recruiting Phase II and III clinical trials using KRAS G12C mutation status as an eligibility criterion. Show sponsor, phase, treatment arm, and contact information.
Drug resistance mechanisms
Research acquired resistance mechanisms to EGFR inhibitors (osimertinib) in non-small cell lung cancer. What genetic alterations are most commonly detected at progression?
Pathway drug landscape
Find all FDA-approved drugs targeting the WNT/beta-catenin signaling pathway. Include mechanism of action, approved indication, and year of approval.
Tools to power your best work
Generate ChartTurn data into chart images fast
Deep ResearchAI research reports with citations
Drug InformationDrug info: recalls & side effects
Diagram GeneratorRender Mermaid, PlantUML & more
Chemistry LookupCompounds, elements, and safety
Clinical TrialsClinical trials & drug safety data
165+ tools.
One conversation.
Everything bioinformatics scientists need from AI, connected to the assistant you already use. No extra apps, no switching tabs.
New analysis method adoption
Evaluate and adopt a new bioinformatics method: benchmark it against alternatives, understand the biological basis, and document the pipeline.
Biomarker strategy for clinical collaboration
Develop a genomic biomarker strategy for a clinical trial collaboration by reviewing the competitive landscape and clinical precedent.
Manuscript figure preparation
Prepare publication-quality figures for a bioinformatics manuscript covering differential expression and pathway analysis.
Frequently Asked Questions
Can academic research access preprint servers like bioRxiv?
Yes. Academic Research includes bioRxiv, medRxiv, and arXiv in addition to PubMed, Semantic Scholar, and other peer-reviewed databases. Preprints are labeled as such in results so you can distinguish them from peer-reviewed publications.
Does chemistry lookup include protein sequence or structural data?
Chemistry Lookup covers small molecule compounds, elements, and basic molecular properties. For protein sequences, PDB structures, and UniProt annotations, you would need to query those databases directly. The tool is most useful for chemical compounds, reagents, and small molecule drugs.
How detailed can the pipeline diagrams be?
Diagram Generator supports Mermaid and Graphviz syntax, which can represent complex multi-branch pipelines with conditional paths, parallel processing steps, and tool-specific annotations. For very large pipelines, break them into sub-diagrams for each major phase.
Can the chart generator produce publication-quality figures?
Generate Chart produces high-resolution PNG images. For journal-specific format requirements (vector SVG, specific fonts, or axes in exact units), you may need to reproduce charts in R (ggplot2) or Python (matplotlib/seaborn) using the same parameters.
How useful is clinical trials search for bioinformatics planning?
Clinical Trials is valuable for understanding how genomic biomarkers are used in clinical development, which sequencing platforms are specified in protocols, and what regulatory precedent exists for your analytical approach. It helps bridge bench research and translational applications.
Give your AI superpowers.
Get started for free
Works in Chat, Cowork and Code